杨静
中国医学科学院阜外医院 麻醉科
OBJECTIVES:To investigate the association of adenosine diphosphate (ADP)-induced platelet maximum amplitude (MAADP) with postoperative bleeding and blood product transfusions in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB).DESIGN:This single-center observational study recruited 200 patients who underwent elective, first-time, isolated CABG with CPB. A rapid thromboelastography with platelet mapping test was conducted for all patients before the surgery. Patients were categorized by the preoperative MAADP into ≤50 mm (MAADP ≤50 group [n = 87]) and MAADP >50 mm (MAADP >50 group [n = 113]). The primary outcome was postoperative bleeding at 6 and 24 hours as measured by chest tube drainage volume. The perioperative blood product transfusions, postoperative complications, postoperative time course, and in-hospital mortality also were evaluated.SETTING:University hospital.PARTICIPANTS:Adult patients scheduled to undergo isolated primary CABG with CPB.INTERVENTIONS:None.MEASUREMENTS AND MAIN RESULTS:The study included 200 patients who underwent CABG with CPB. MAADP was >50 mm in 113 (56.5%) patients (MAADP >50 group). Compared with the MAADP >50 group, the postoperative chest tube drainage volume at 6 and 24 hours was significantly greater in the patients with MAADP ≤50 mm (476.90 ± 156.36 mL v 403.36 ± 133.24 mL; p < 0.001 and 935.86 ± 318.43 mL v 667.21 ± 222.75 mL; p < 0.001, respectively). The consumption of blood products in patients with MAADP ≤50 mm was significantly more than those with MAADP >50 mm. The durations of intensive care unit stay and length of postoperative hospital stay were markedly longer in the MAADP ≤50 group than in the MAADP >50 group (p = 0.001 and p = 0.005; respectively). There were no significant differences in adverse outcomes between the 2 groups except for the postoperative atrial fibrillation, which occurred more in the MAADP ≤50 group than in the MAADP >50 group (8.05% v 1.77%; p = 0.043). MAADP (area under the receiver operating characteristic curve of 0.767; p < 0.001) was demonstrated to have significant ability to predict bleeding tendency, with a sensitivity of 76.2% and a specificity of 69.0%.CONCLUSIONS:Preoperative MAADP may play a potential role in the prediction of postoperative bleeding and allogeneic blood transfusions and guide clinicians in perioperative management of patients undergoing CABG with CPB.
Journal of cardiothoracic and vascular anesthesia 2021
BACKGROUND:Delirium is a frequent complication after cardiac surgery and its occurrence is associated with poor outcomes. The purpose of this study was to investigate the impact of perioperative dexmedetomidine administration on the incidence of delirium in elderly patients after cardiac surgery.METHODS:This randomized, double-blinded, and placebo-controlled trial was conducted in two tertiary hospitals in Beijing between December 1, 2014 and July 19, 2015. Eligible patients were randomized into two groups. Dexmedetomidine (DEX) was administered during anesthesia and early postoperative period for patients in the DEX group, whereas normal saline was administered in the same rate for the same duration for patients in the control (CTRL) group. The primary endpoint was the incidence of delirium during the first five days after surgery. Secondary endpoints included the cognitive function assessed on postoperative days 6 and 30, the overall incidence of non-delirium complications within 30 days after surgery, and the all-cause 30-day mortality.RESULTS:Two hundred eighty-five patients were enrolled and randomized. Dexmedetomidine did not decrease the incidence of delirium (4.9% [7/142] in the DEX group vs 7.7% [11/143] in the CTRL group; OR 0.62, 95% CI 0.23 to 1.65, p = 0.341). Secondary endpoints were similar between the two groups; however, the incidence of pulmonary complications was slightly decreased (OR 0.51, 95% CI 0.26 to 1.00, p = 0.050) and the percentage of early extubation was significantly increased (OR 3.32, 95% CI 1.36 to 8.08, p = 0.008) in the DEX group. Dexmedetomidine decreased the required treatment for intraoperative tachycardia (21.1% [30/142] in the DEX group vs 33.6% [48/143] in the CTRL group, p = 0.019), but increased the required treatment for postoperative hypotension (84.5% [120/142] in the DEX group vs 69.9% [100/143] in the CTRL group, p = 0.003).CONCLUSIONS:Dexmedetomidine administered during anesthesia and early postoperative period did not decrease the incidence of postoperative delirium in elderly patients undergoing elective cardiac surgery. However, considering the low delirium incidence, the trial might have been underpowered.TRIAL REGISTRATION:ClinicalTrials.gov NCT02267538.
PloS one 2017
OBJECTIVE:To evaluate the effects of adenosine on reducing myocardial injuries in patients undergoing off-pump coronary artery bypass grafting (OPCAB).METHODS:Forty patients undergoing OPCAB were allocated into two equal groups randomly: adenosine (ADO) group and control group. The patients in the ADO group were given infusion of adenosine through the central venous catheter via internal jugular vein when the surgeons dissociated the internal mammary artery. The initial infusion rate was 50 microg.kg(-1).min(-1), the infusion speed increased every minute until the dose of 150 microg.kg(-1).min(-1), and the total duration of adenosine infusion lasted for 10 min. The patients of the control group received intravenous infusion of 0.9% saline instead during the infusion period. 5 min after the completion of adenosine or saline infusion protocol, revascularization began. Blood samples were collected at following time points: T0 (10 minutes after anesthesia), T1, T2, T3, T4, and T5 (30 minutes, and 2, 6, 12, and 24 hours after revascularization respectively). Levels of MB isoenzyme of creatine kinase (CK-MB) and cardiac troponin I (cTnI) were measured.RESULTS:The CK-MB levels of the control group increased from T1 to T5 (all P < 0.05), and the CK-MB level of the ADO group increased only at T2 (P < 0.05), however, the level of CK-MB 24 h after revascularization of the control group was significantly higher than that of the ADO group (P < 0.05). The cTnI level increased significantly after revascularization (from T1 to T5) in both group (all P < 0.05), and the cTnI levels of the control group were higher than those of the ADO group at all time points, and were significantly higher at T4 and T5 points (both P < 0.05).CONCLUSION:OPCAB can cause myocardial injuries which can be reduced by adenosine preconditioning through the reduction of the release of CK-MB and cTnI.
Zhonghua yi xue za zhi 2007